ORPEA Group: Mr Philippe Charrier, Chairman and CEO, Responds to Mirova';s Letter

Rhea-AI Summary

ORPEA, represented by Chairman Philippe Charrier, acknowledges Mirova's concerns about end-of-life care. The company expresses commitment to proper care for residents and families, emphasizing the importance of collaboration between private and public sectors. ORPEA plans to address the suggestions made in Mirova's letter to the Board of Directors. Two independent firms have been engaged to investigate allegations against the Group, with findings to be shared with the market and stakeholders.

Positive

• Engagement of two independent world-renowned firms for assessment
• Commitment to addressing end-of-life care issues
• Open to constructive proposals and feedback from stakeholders

Negative

• Allegations against the Group may raise concerns among investors
• Need for independent assessments indicates previous issues within the Group

PUTEAUX, France--(BUSINESS WIRE)-- Regulatory News:

In my capacity as Chairman of the Board of Directors, I would like to thank Mirova for its letter dated 7 February. ORPEA (Paris:ORP) fully shares the concerns raised in this letter.

Please rest assured that we continue to be fully committed to the proper and caring treatment of our residents, patients, families and employees.

We too are convinced that end-of-life care is a major social issue where the private sector must complement public action.

I also welcome the constructive proposals made in this letter.

I undertake to submit to the Board of Directors and its competent committees all the proposals made and I will ensure that a response is given to the questions raised.

ORPEA wishes to point out that its Board of Directors has already taken all the necessary steps to shed light on the allegations made against the Group.

In particular, two independent world-renowned firms have been mandated to carry out the necessary assessments within the Group, the conclusions of which will be the subject of a specific communication to the market and the Board of Directors will draw all the necessary conclusions in the interest of all stakeholders.

Philippe CHARRIER
Chairman and CEO

View source version on businesswire.com: https://www.businesswire.com/news/home/20220209006015/en/

ORPEA Group

Source: ORPEA Group

FAQ

What are the main concerns raised by Mirova regarding ORPEA?

Mirova's letter highlighted concerns about end-of-life care and the private sector's role in addressing social issues.

How is ORPEA responding to the allegations against it?

ORPEA has engaged two independent firms for assessments and will communicate findings to the market.

Who is the Chairman and CEO of ORPEA?

Philippe Charrier is the Chairman and CEO of ORPEA.

What commitment has ORPEA made regarding resident care?

ORPEA is committed to ensuring proper and caring treatment for its residents, patients, families, and employees.

What actions will ORPEA take based on Mirova's proposals?

ORPEA plans to submit Mirova's proposals to the Board of Directors and address the raised questions.